EPA and DHA supplementation significantly lowers inflammatory markers in coronary artery disease patients
Fish oil supplements may lower inflammation in heart disease patients
This secondary analysis of a randomized trial involved 240 patients with stable coronary artery disease on statin therapy. Supplementation w…
A study shows that taking specific fish oils can lower certain markers of inflammation in people with coronary artery disease.
DHA and ARA supplementation significantly reduces risk of severe retinopathy of prematurity in preterm infants
DHA and ARA Supplementation May Reduce Severe Retinopathy Risk
This meta-analysis of randomized trials evaluates enteral DHA and ARA supplementation for retinopathy of prematurity (ROP) in preterm infant…
Supplementing preterm infants with DHA and ARA may lower the risk of severe, sight-threatening eye conditions like retinopathy of prematurit…
Combined EPA and DHA supplementation showed no broad benefit for major adverse cardiovascular events in patients with established disease
New research shows combined fish oil supplements did not lower heart attack risk for patients with existing heart disease
This meta-analysis evaluated combined eicosapentaenoic acid and docosahexaenoic acid supplementation in patients with established cardiovasc…
A large study of over 25,000 patients found that taking moderate doses of EPA and DHA together did not significantly reduce major heart even…
Systematic review and meta-analysis of n-3 PUFAs for pancreatic cancer patients
Omega-3 fats show modest weight gain in pancreatic cancer patients
This systematic review and meta-analysis of nine randomized controlled trials evaluated n-3 polyunsaturated fatty acid supplementation in pa…
A review of nine trials found omega-3 fats helped pancreatic cancer patients gain a little weight, but did not improve muscle or blood prote…